Concepedia

Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe

Michael Drummond, Dominique Dubois, Livio Garattini, Bruno Horisberger, Bengt Jönsson, Ivar S. Kristiansen, Claude Le Pen, Carlos Gouveia Pinto, Peter Bo Poulsen, Joan Rovira,

Value in Health · 1999 · 75 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Methods for the economic evaluation of health care programmes

Sandra Wilson · Journal of Epidemiology & Community Health · 1987 · 4.3K citations · Full text

, , +13

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin

J. Jaime, Wendy S. Klittich, Alistair McGuire et al. · BMJ · 1997 · 204 citations · Full text

, , +16

Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S)

Bengt Jönsson, Magnus Johannesson, John Kjekshus et al. · European Heart Journal · 1996 · 176 citations · Full text

, , +17

The role of economic evaluation in the pricing and reimbursement of medicines

Michael Drummond, Bengt Jönsson, Frans Rutten · Health Policy · 1997 · 130 citations

, , +12

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

Maureen Rutten‐van Mölken, Eddy van Doorslaer, M.C.C. Jansen et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 111 citations

, , +17